ANKRD13A expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.304800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.670200E-01
Normal-vs-Stage2
2.301600E-01
Normal-vs-Stage3
2.001200E-01
Normal-vs-Stage4
2.029200E-01
Stage1-vs-Stage2
3.443600E-01
Stage1-vs-Stage3
1.157800E-01
Stage1-vs-Stage4
1.167640E-01
Stage2-vs-Stage3
3.753000E-01
Stage2-vs-Stage4
4.446600E-01
Stage3-vs-Stage4
8.450400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.305400E-01
Normal-vs-AfricanAmerican
2.299400E-01
Normal-vs-Asian
2.316600E-01
Caucasian-vs-AfricanAmerican
9.069200E-01
Caucasian-vs-Asian
9.734000E-01
AfricanAmerican-vs-Asian
9.334200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.284400E-01
Normal-vs-Female
2.339800E-01
Male-vs-Female
6.431800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.926640E-01
Normal-vs-Age(41-60Yrs)
2.437800E-01
Normal-vs-Age(61-80Yrs)
2.250400E-01
Normal-vs-Age(81-100Yrs)
2.230200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.394600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.795800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.427200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.119570E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.496200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.110600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.113400E-01
Normal-vs-Daily Drinker
2.172200E-01
Normal-vs-Weekly Drinker
2.226400E-01
Normal-vs-Occasional Drinker
2.365000E-01
Normal-vs-Social Drinker
2.330000E-01
Non Drinker-vs-Daily Drinker
7.422800E-01
Non Drinker-vs-Weekly Drinker
6.279800E-01
Non Drinker-vs-Occasional Drinker
2.603600E-01
Non Drinker-vs-Social Drinker
3.621200E-01
Daily Drinker-vs-Weekly Drinker
7.929800E-01
Daily Drinker-vs-Occasional Drinker
3.222600E-01
Daily Drinker-vs-Social Drinker
4.383000E-01
Weekly Drinker-vs-Occasional Drinker
5.283400E-01
Weekly Drinker-vs-Social Drinker
6.485200E-01
Occasional Drinker-vs-Social Drinker
8.719800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.626200E-01
Normal-vs-Grade 2
6.423000E-01
Normal-vs-Grade 3
6.597200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.383000E-01
Grade 1-vs-Grade 3
3.603200E-01
Grade 1-vs-Grade 4
3.626200E-01
Grade 2-vs-Grade 3
7.264800E-01
Grade 2-vs-Grade 4
6.423000E-01
Grade 3-vs-Grade 4
6.597200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.343800E-01
Normal-vs-NonDiabetic
2.228600E-01
Diabetic-vs-NonDiabetic
4.011200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.132400E-01
Normal-vs-NoPancreatitis
2.265400E-01
Pancreatitis-vs-NoPancreatitis
2.903000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.349800E-01
Normal-vs-N1
2.275600E-01
N0-vs-N1
6.537600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.081400E-01
Normal-vs-TP53-NonMutant
2.543000E-01
TP53-Mutant-vs-TP53-NonMutant
8.637400E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
